← Browse by Condition
Medical Condition
small lymphocytic lymphoma sll
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 2
NCT07221500 Phase 2
Recruiting
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
Enrollment
100 pts
Location
United States, Franc...
Sponsor
Nurix Therapeutics, Inc.
NCT06788639
Recruiting
A Study of Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Treated With Lisocabtagene Maraleucel in the Post-Marketing Setting
Enrollment
300 pts
Location
United States
Sponsor
Juno Therapeutics, Inc., a Bri...